top of page

Biopharma Daily Stock Updates - 01/22/21

$XBI $152.56 (+1.18%) 📈


COVID:

$AMPE (+16.13%) - AMPIO PHARMACEUTICALS ONGOING PHASE I CLINICAL TRIAL FOR INHALATION TREATMENT OF COVID-19 WITH AMPION IS 55% ENROLLED


$PFE (+0.14%) & $BNTX (+2.85%) - Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19


$HGEN (+4.37%) - Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19


PIPELINE:

$BCRX (+0.71%) - BioCryst Announces Approval of ORLADEYO™ (berotralstat) in Japan for the Prophylactic Treatment of Hereditary Angioedema


$SPPI (+1.27%) - Spectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung Cancer


FINANCIAL:

$PGEN (+0.77%) - Pricing of an underwritten public offering of 15,000,000 shares of its common stock at a public offering price of $7.50 per share.


$FULC (+0.07%) - Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares


$DBVT (-8.49%)


0 comments

Comments


bottom of page